Form 8-K - Current report:
SEC Accession No. 0001104659-21-097239
Filing Date
2021-07-29
Accepted
2021-07-29 07:01:02
Documents
17
Period of Report
2021-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2123400d1_8k.htm   iXBRL 8-K 36517
2 EXHIBIT 99.1 tm2123400d1_ex99-1.htm EX-99.1 594341
3 EXHIBIT 99.2 tm2123400d1_ex99-2.htm EX-99.2 602289
8 GRAPHIC tm2123400d1_ex99-1img003.jpg GRAPHIC 12480
9 GRAPHIC tm2123400d1_ex99-1img004.jpg GRAPHIC 4221
  Complete submission text file 0001104659-21-097239.txt   1565709

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrk-20210729.xsd EX-101.SCH 4499
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20210729_def.xml EX-101.DEF 28713
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20210729_lab.xml EX-101.LAB 38997
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20210729_pre.xml EX-101.PRE 27322
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2123400d1_8k_htm.xml XML 8771
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 211124762
SIC: 2834 Pharmaceutical Preparations